ANI Pharmaceuticals Inc
NASDAQ:ANIP
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
48.72
69.69
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
ANI Pharmaceuticals Inc
Wall Street
Price Targets
ANIP Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ANIP
is 75.99 USD
with a low forecast of 62.62 USD and a high forecast of 88.2 USD.
ANIP Last Price Targets
ANI Pharmaceuticals Inc
The latest public price target was made on Sep 18, 2024 by
Gary Nachman
from
Raymond James
,
who expects
ANIP
stock to
rise by 43%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Gary Nachman
Raymond James
|
83
USD
Upside 43% |
2 months ago
Sep 18, 2024
|
ANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
TheFly
|
Les Sulewski
Truist Financial
|
60
USD
Upside 4% |
2 months ago
Sep 11, 2024
|
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
TheFly
|
|
Oren Livnat
H.C. Wainwright
|
94
USD
Upside 62% |
5 months ago
Jun 26, 2024
|
ANI Pharmaceuticals (ANIP) PT Raised to $94 at H.C. Wainwright
StreetInsider
|
|
Oren Livnat
H.C. Wainwright
|
87
USD
Upside 50% |
6 months ago
May 13, 2024
|
ANI Pharmaceuticals (ANIP) PT Raised to $87 at H.C. Wainwright
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
ANI Pharmaceuticals Inc
For the last 8 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's operating income is
5%.
The projected
CAGR
for the next 3 years is
65%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANIP's stock price target?
Price Target
75.99
USD
According to Wall Street analysts, the average 1-year price target for
ANIP
is 75.99 USD
with a low forecast of 62.62 USD and a high forecast of 88.2 USD.
What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's revenue is
26%.
The projected
CAGR
for the next 3 years is
16%.
What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
65%
For the last 8 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's operating income is
5%.
The projected
CAGR
for the next 3 years is
65%.
What is ANI Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
106%
For the last 8 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's net income is
0%.
The projected
CAGR
for the next 3 years is
106%.
You don't have any saved screeners yet
